ArticleAI and ethics2026
Hyper-selective explainability: an empirical case study of the utility of explainability in a clinical decision support system.
Article in AI and ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Explainability is a leading solution offered to address the challenge of AI's black boxing. However, a lot can go wrong when trying to apply explainability, and its success is far from certain. Moreover, there is insufficient empirical data regarding the effectiveness of concrete explainability efforts. We examined an explainability scenario for an AI decision support tool under development for the early detection of cancer-related cachexia, a potentially fatal metabolic syndrome. We conducted 13 interviews with clinicians who deal with cachexia, and asked about their prior experience with AI tools, their views on explainability, and presented an explainability scenario based on the Shapley Additive Explanations (SHAP) method. Most clinicians we interviewed had limited prior experience with AI tools, and a majority of them believed that the explainability of such an AI system for the early detection of cachexia is essential. When presented with the SHAP explainability scheme, they had limited familiarity with the features that contributed to the tool's ruling, and only a minority of the clinicians (nuclear medicine experts) stated that they could utilize these features in a meaningful manner. Paradoxically, it is the clinicians who come in contact with patients who cannot make use of this specific SHAP explanation. This study highlights the challenges of offering a hyper-selective explainability tool in clinical settings. It also shows the challenge of developing explainable-by-design AI systems. Supplementary Information: The online version contains supplementary material available at 10.1007/s43681-025-00837-y.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.